Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

NanJing Pharmaceutical Co Ltd and Subsidiary to Sell Equity Shares


Thursday, 22 Aug 2013 08:00pm EDT 

NanJing Pharmaceutical Co Ltd announced that it will sell a 5.01% stake in a Xuzhou-based medicine company for not less than RMB 9.5558 million, and a Hefei-based subsidiary of the Company will sell a 29.29% stake in a Huangshan-based medicine company, for not less than RMB 2000. As a result, the Company and the subsidiary of the Company will hold no stake in the two target companies, respectively. 

Company Quote

9.46
0.0 +0.00%
27 Feb 2015